CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,000 | 0.0% | 211 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 211 | -39.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 346 | -41.9% | 0.00% | – |
| Q1 2016 | $2,000 | -85.7% | 596 | -34.1% | 0.00% | -100.0% |
| Q4 2015 | $14,000 | +40.0% | 905 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $10,000 | -33.3% | 905 | +51.1% | 0.00% | 0.0% |
| Q2 2015 | $15,000 | – | 599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |